Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Gregory R Friberg

Evp, Chief R&D Officer at Biomarin Pharmaceutical Inc (BMRN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $559K

Reported trades

Filed Stock Type Shares Price Value Since
May 11SEC BMRNBiomarin Pharmaceutical Inc Sell 3,28151,818 held (−6%) $53.85 $177K +1.5%
Feb 26SEC BMRNBiomarin Pharmaceutical Inc Sell 6,32637,578 held (−14%) $60.38 $382K -9.4%